GeneOne Life Science, Inc.(KR:011000)
₩2,670.000.00 (0.00%)
KR:011000
GeneOne Life Science, Inc. financials statements
₩2,670.00
At close:0.00 (0.00%)
Want to see KR:011000 full AI Analyst Report?
GeneOne Life Science, Inc. (011000) Income Statement
GeneOne Life Science, Inc. Income Statement
Last quarter (Q1 2026), GeneOne Life Science, Inc.'s total revenue was ₩2.58B, a decrease of 69.65% from the same quarter last year. In Q1, GeneOne Life Science, Inc.'s net income was ₩-2.38B. See GeneOne Life Science, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 23.93B | ₩ 35.72B | ₩ 40.20B | ₩ 48.72B | ₩ 38.70B | |
| ₩ -21.43B | ₩ -10.87B | ₩ -7.76B | ₩ 9.34B | ₩ 8.76B | |
| ₩ 21.00B | ₩ 32.17B | ₩ 40.61B | ₩ 49.42B | ₩ 36.26B | |
| Depreciation and Amortization | ₩ 18.20B | ₩ 17.96B | ₩ 12.78B | ₩ 5.42B | ₩ 4.65B |
| ₩ -28.60B | ₩ -28.64B | ₩ -63.70B | ₩ -25.32B | ₩ -6.51B | |
| ₩ -42.42B | ₩ -43.04B | ₩ -48.37B | ₩ -40.08B | ₩ -27.51B | |
| ₩ -5.15B | ₩ -5.71B | ₩ -29.29B | ₩ 2.03B | ₩ 11.90B | |
| ₩ -47.57B | ₩ -48.75B | ₩ -77.65B | ₩ -38.05B | ₩ -15.62B | |
| ₩ -47.66B | ₩ -48.54B | ₩ -77.77B | ₩ -38.15B | ₩ -15.95B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -13951.00 | ₩ -15220.25 | ₩ -25005.75 | ₩ -12308.75 | ₩ -5371.50 |
| Diluted EPS | ₩ -13951.00 | ₩ -15220.25 | ₩ -25005.75 | ₩ -12308.75 | ₩ -5371.50 |
| Weighted Average Shares Outstanding | 3.42M | 3.18M | 3.11M | 3.10M | 2.97M |
| Weighted Average Shares Outstanding (Diluted) | 3.42M | 3.18M | 3.11M | 3.10M | 2.97M |
Currency in KRW

